US › Healthcare

bioAffinity Technologies, Inc. (BIAF)

US · Healthcare · Diagnostics & Research

$2.71+4.42%

Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue

$1.5M

Revenue YoY

+19.0%

Net profit

$-3.4M

EPS

$-0.64

Net margin

-222.8%

Key statistics

Market cap

$3.3M

Forward P/E

0.0

P/B

0.42

Book value

$8.34

EPS (TTM)

$-109.35

52-week high

$80.70

52-week low

$2.54

50-day MA

$5.95

200-day MA

$18.90

Beta

-1.05

Analyst view

with an average price target of $6.00.

Shareholding

Insiders

0.76%

Institutions

4.82%

Largest institutional holders

Fund	Stake
Sabby Management LLC	8.13%
BlackRock Inc	2.20%
Vanguard Capital Management, LLC	1.23%
Geode Capital Management, LLC	1.13%
J. Safra Sarasin Holding AG	0.95%
Vanguard Fiduciary Trust Co	0.69%
Susquehanna International Group, LLP	0.60%
Jane Street Group LLC	0.60%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for bioAffinity Technologies, Inc. — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-11-07.